Health Monitor Advisory Board

Arlan L. Rosenbloom, MD, is an adjunct distinguished service professor emeritus of pediatrics at the University of Florida College of Medicine. He has served on numerous editorial boards and review committees for U.S. and international grant agencies. He has also chaired the National Diabetes Commission task force that created the National Diabetes Data Group and authored/co-authored 375 articles and 80 chapters or books on diabetes and growth.

Fred Whitehouse, MD, is division head emeritus in the division of endocrinology and metabolism at Henry Ford Hospital in Detroit. He is board certified in internal medicine and endocrinology and metabolism. His clinical interests include type 1 and type 2 diabetes, hypoglycemia, weight problems and other endocrinological issues.

Gregory F. Schimizzi, MD, is the cofounder of Carolina Arthritis Associates, PA, in Wilmington, NC, and has been a licensed and board-certified rheumatologist in private practice for 30 years. He's also affiliated with Coalition of State Rheumatology Associations. North Carolina Rheumatology Association, American College of Rheumatology, New Hanover-Pender Medical Society, American College of Physicians and National Association of Parliamentarians.

John D. Hainsworth, MD, is the chief scientific officer at The Sarah Cannon Research Institute and a partner in Tennessee Oncology, PLLC, both in Nashville. He has been published extensively in the areas of unknown primary cancer, lung cancer and lymphoma.

John Varga, MD, is director of the Northwestern Scleroderma Program and the John and Nancy Hughes Professor in the Division of Rheumatology at Northwestern University, Feinberg School of Medicine in Chicago. He is an internationally recognized expert on fibrosis and scleroderma. He chairs the scientific and medical advisory board of the Scleroderma Foundation and the Basic Science Subcommittee of the American College of Rheumatology Planning Committee.

Lillie D. Shockney, RN, BS, MAS, is administrative director of the Johns Hopkins Avon Foundation Breast Center and the Johns Hopkins Cancer Survivorship Program. She is responsible for quality of care programs; patient education programs; the survivor volunteer team; community outreach; the website and patient advocacy. The two-time breast cancer survivor is also editor-in-chief of the peer-reviewed medicine journal Journal of Oncology Navigation and Survivorship and serves on the Leadership Council of the Academy of Oncology Nurse Navigators (AONN).

Lisa Robins is a fitness expert, writer and mother. Her work has been published in national magazines such as Oxygen, Max Sports & Fitness , Muscle & Fitness Hers , Scottsdale Health and more.

Marc Garnick, MD, is a clinical professor of medicine at Harvard Medical School and director of Cancer Network Services at Beth Israel Deaconess Medical Center, both in Boston. He also serves as editor-in-chief of Harvard Medical School's annual report on prostate diseases. His specialties include internal medicine and medical oncology.

Michael Glode, MD, is a professor at Washington University in St. Louis in the Department of Medicine and Division of Medical Oncology.

Michael H. Weisman, MD, is director of the Division of Rheumatology and professor of Medicine at Cedars-Sinai Medical Center in Los Angeles. His academic and research interests involve the genetic risk, epidemiology, treatment and outcome of rheumatic diseases. He is also an investigator for NIH-sponsored